Year: 2015
Type: article
Abstract: ) can be achieved in pseudo prospective approach. Bromodomains are epigenetic mark readers that recognize acetylation motifs and regulate gene transcription, and are currently being investigated as therapeutic targets for cancer and inflammation. The unprecedented accuracy offers the exciting prospect that the binding free energy of drug-like compounds can be predicted for pharmacologically relevant targets.
Source: Chemical Science
DOI: 10.1039/c5sc02678d
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: diamond
Funders: Eli Lilly and Company, GlaxoSmithKline, Genome Canada, Wellcome Trust, Ontario Ministry of Economic Development and Innovation, University of Southampton, Imperial College London, Ministero dello Sviluppo Economico, University of California, Irvine, Engineering and Physical Sciences Research Council
OpenAlex ID: W2103034037
